London-based Lindus Health, which has built a software platform for running clinical trials, raised a $55M Series B led by Balderton Capital (Paul Sawers/TechCrunch)

Paul Sawers / TechCrunch:
London-based Lindus Health, which has built a software platform for running clinical trials, raised a $55M Series B led by Balderton Capital  —  A four-year-old London startup backed by Peter Thiel has raised a $55 million Series B round as it sets about “fixing the broken clinical trial industry.”